KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Current Leases (2019 - 2025)

Historic Current Leases for CRISPR Therapeutics AG (CRSP) over the last 7 years, with Q3 2025 value amounting to $18.3 million.

  • CRISPR Therapeutics AG's Current Leases rose 813.24% to $18.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.3 million, marking a year-over-year increase of 813.24%. This contributed to the annual value of $17.3 million for FY2024, which is 1064.32% up from last year.
  • Latest data reveals that CRISPR Therapeutics AG reported Current Leases of $18.3 million as of Q3 2025, which was up 813.24% from $18.0 million recorded in Q2 2025.
  • CRISPR Therapeutics AG's Current Leases' 5-year high stood at $18.3 million during Q3 2025, with a 5-year trough of $8.3 million in Q2 2022.
  • For the 5-year period, CRISPR Therapeutics AG's Current Leases averaged around $14.8 million, with its median value being $15.7 million (2023).
  • In the last 5 years, CRISPR Therapeutics AG's Current Leases tumbled by 4792.44% in 2022 and then skyrocketed by 7942.42% in 2023.
  • CRISPR Therapeutics AG's Current Leases (Quarter) stood at $12.2 million in 2021, then skyrocketed by 30.3% to $15.8 million in 2022, then fell by 1.37% to $15.6 million in 2023, then rose by 10.64% to $17.3 million in 2024, then grew by 5.6% to $18.3 million in 2025.
  • Its Current Leases stands at $18.3 million for Q3 2025, versus $18.0 million for Q2 2025 and $17.5 million for Q1 2025.